PATH-03. CLINICAL UTILITY OF NEXT GENERATION SEQUENCING IN IDH-WILDTYPE GLIOBLASTOMA: THE DANA-FARBER CANCER INSTITUTE EXPERIENCE

BACKGROUND: Comprehensive next generation sequencing (NGS) is available through many academic institutions and commercial entities, and is incorporated in practice guidelines for glioblastoma (GBM). We retrospective evaluated the practice patterns and utility of incorporating NGS data into routine c...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Jane Lim-Fat, Mary, Youssef, Gilbert, Touat, Mehdi, Iorgulescu, Bryan, Woodward, Eleanor, Whorral, Sydney, Allen, Marie, Vogelzang, Jayne, Pisano, William, Rahman, Rifaquat, Chukwueke, Ugonma, Mcfaline-Figueroa, Jose, Nayak, Lakshmi, Lee, Eudocia, Batchelor, Tracy, Chiocca, E Antonio, Meredith, David, Santagata, Sandro, Reardon, David, Beroukhim, Rameen, Bi, Wenya Linda, Ligon, Keith, Wen, Patrick
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Molecular Pathology & Classification
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650887/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.685
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items